Creekmur Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$24.4K Hold
957
﹤0.01% 414
2025
Q2
$23.2K Buy
957
+237
+33% +$5.53K ﹤0.01% 422
2025
Q1
$18.2K Sell
720
-48
-6% -$1.26K ﹤0.01% 413
2024
Q4
$20.4K Hold
768
﹤0.01% 332
2024
Q3
$22.2K Hold
768
0.01% 332
2024
Q2
$21.5K Sell
768
-456
-37% -$12.6K 0.01% 370
2024
Q1
$34K Buy
1,224
+117
+11% +$3.25K 0.01% 303
2023
Q4
$31.9K Buy
+1,107
New +$33.5K 0.01% 363

Other funds holding PFE

Creekmur Asset Management's PFE Position: Q3 2025 in Review

Creekmur Asset Management held its Pfizer (PFE) position steady in Q3 2025 at 957 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #414.

Creekmur Asset Management first reported a position in PFE in Q4 2023 and has held it in 8 quarters since. The position peaked at $34K in Q1 2024. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Creekmur Asset Management held 957 shares of Pfizer worth $24.4K as of Q3 2025.
  • Creekmur Asset Management left its Pfizer share count unchanged in Q3 2025.
  • Pfizer made up ﹤0.01% of Creekmur Asset Management's portfolio in Q3 2025, its #414 holding.
  • Creekmur Asset Management first reported a position in Pfizer in Q4 2023 and has held it in 8 quarters since.
  • Creekmur Asset Management's Pfizer position peaked at $34K in Q1 2024.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.